Cyagen will be exhibiting at the ARVO Annual Meeting 2025, held May 4–8 in Salt Lake City, Utah. Visit us at Booth #1908 to explore our cutting-edge animal models and CRO services supporting retinal degeneration, corneal dystrophy, Stargardt disease, Usher syndrome, and other ophthalmic conditions.

Discover how our humanized and inducible models help researchers accelerate the development of therapies for vision-related disorders.

• Cyagen Booth: 1908
• Dates: May 4-8, 2025
• Location: Calvin L. Rampton Salt Palace Convention Center | Salt Lake City, Utah
  
  

We would be thrilled to meet with you at ARVO to answer any questions you may have and discuss potential collaborations that could accelerate the advancement of your ophthalmology research projects.

Let's connect on advancing vision science.

Request a Free Project Consultation

This event presents an excellent opportunity for us to meet in person and discuss how Cyagen’s specialized services, including our cutting-edge ophthalmology research solutions, can support your ongoing and future research projects. Request an in-person meeting at ARVO 2025 to discuss your project here!

If you are interested in scheduling a free consultation on your CAM/CGT projects outside of the event, please Contact Us.  

One-Stop Preclinical Ophthalmology Research Solutions

Cyagen offers a range of standard preclinical research solutions for ophthalmic gene therapy:

• Abundant Animal Models Of Ophthalmic Diseases
  
  

• • HUGO-GT™ (Humanized Genomic Ortholog for Gene Therapy) Next-Generation Humanized Ophthalmic Models (B6J-hRHO Mice, B6-hVEGFA Mice etc.), Conventional Genetic Ophthalmic Disease Models (Nr2e3 KO Mice, Pde6b-MU1 Mice etc.) and Inducible Ophthalmic Disease Models (Ischemia-Reperfusion-Induced Glaucoma, Y-79 cells-Induced RB etc.)
    
    
• State-Of-The-Art Ophthalmic Instruments For Small Animals
  
  
  • Like Phoenix-Micron IV Retinal Imaging Microscope, Diagnosys Celeris ERG, Icare Ophthalmotonometer and Laser photocoagulation system etc.
    
    
• Comprehensive ophthalmic pharmacodynamics analysis platform
  
  

• • Different types of injections (Overall >90% success rate)
    
    
    • Intracameral injection, Intravitreal injection, Subretinal injection, Subconjunctival injection and Retrobulbar injection
      
      
  • Live animal ophthalmic examination
    
    
    • Fundus photography (FP), Fundus autofluorescence  (GFP/mCherry) imaging, Fundus fluorescein angiography (FFA) and Optical Coherence Tomography (OCT) etc.
      
      
  • In Vitro/ex vivo Assays
    
    
    • Pathological analysis: Immunofluorescence, Immunohistochemistry, H&E stain, Retinal flat-mounts, RPE and choroidal flat-mounts
      
      
    • Molecular/biochemical assays: Western Blot, Quantitative real-time PCR (qPCR), Droplet digital PCR (ddPCR) and ELISA

About Cyagen

Founded in 2006, Cyagen is a global provider of genetically modified rodent models and innovative cell and gene therapy (CGT) solutions for research and development (R&D), including: disease model development, AAV discovery, drug efficacy studies, and more. The company has established extensive collaborations with scientists and institutions in more than 100 countries, leading to the publication of over 6,300 academic articles, many of which were in the three major journals of CNS (Cell, Nature, Science). From its robust foundation in animal model development, to implementation of artificial intelligence (AI)-powered tools for data analysis and therapeutic discoveries, Cyagen provides one-stop solutions for accelerating basic research and new drug R&D with our unique offering of models, data, algorithms, and services.